Abstract Emerging diseases require generating new vaccines, which can often be time-consuming. An alternate method to boost host defense is by inducing nonspecific innate immune memory, called trained immunity, develop novel prophylactics. Many molecules, most notably β-glucan, induce but their effects are short-lived and uncontrolled. This lack of temporal control limits both the therapeutic a...
